Granules India Ltd. Financials

NSE BSE

15:59 Jul 31

Granules India Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

474.90

-17.25 (-3.51%)

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

NSE BSE

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals

474.90

-17.25 (-3.51%)
15:59 Jul 31

Quality

68/100
High Financial Strength

Valuation

50/100
Mid Valuation

Technical

38/100
Technically Neutral

Strength

Weakness

Opportunity

Threats

ROE %

ROA %

EPS

BVPS

Net Profit Margin

Income Statement Balance sheet Cash flow Ratio Shareholding

Quarterly Annual

Consolidated Standalone

	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Net Sales	3237.54	3764.92	4511.92	4506.37	4481.61
Operating Expenses +	2382.32	3042.69	3598.1	3650.39	3536.37
Raw Material	1590.28	2036.42	2352.65	2208.22	1724.94
Increase Decrease in Cost	-199	-152.78	-45.37	-186.97	0.76
Other Manufacturing Expense	17.26	22.01	19.98	0	0
Employee Cost	408.18	401.38	472.23	597.86	659.8
Miscellaneous Expenses	565.6	735.66	798.61	1031.28	1150.87
Operating Profit	855.22	722.23	913.82	855.98	945.24
Other Income	26.88	17.61	13.78	4.4	12.92
Depreciation	151.46	158.63	184.49	207.33	225.5
Interest	26.28	23.21	55.93	105.82	103.24
Profit before tax and exceptio..	704.36	558	687.17	547.23	629.42
Exceptional Items	0	0	0	0	30.75
PBT	704.36	558	687.17	547.23	660.17
Provision for Taxation	154.91	145.24	170.58	141.92	158.65
Net Profit	549.46	412.76	516.6	405.31	501.52
NET Profit after MI	549.46	412.76	516.6	405.31	501.52
EPS	21.95	16.6	21	16.73	20.68
Operating Profit Margin (%)	26.42	19.18	20.25	18.99	21.09
Net Profit Margin (%)	16.97	10.96	11.45	8.99	11.19

All Data in Percentage (%)

	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24
Promoter	38.80	38.80	38.80	38.90	38.90
FII	13.20	15.10	15.90	19.50	20.40
MF	12.20	11.60	10.40	7.90	9.20
Others	11.40	10.90	9.10	6.90	4.90

Promoter Non-Promoter

Shareholder	Shares	Holding %

Download Our App On: